Envestnet Asset Management
AXSM icon

Envestnet Asset Management’s Axsome Therapeutics AXSM Stock Holding History

Envestnet Asset Management’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.16M Buy
30,555
+64
+0.2% +$11.1K ﹤0.01% 2292
2025
Q4 		$5.57M Sell
30,491
-851
-3% -$119K ﹤0.01% 2104
2025
Q3 		$3.81M Buy
31,342
+3,205
+11% +$361K ﹤0.01% 2441
2025
Q2 		$2.94M Buy
28,137
+3,094
+12% +$328K ﹤0.01% 2547
2025
Q1 		$2.92M Sell
25,043
-10,086
-29% -$1.15M ﹤0.01% 2476
2024
Q4 		$2.97M Buy
35,129
+15,047
+75% +$1.38M ﹤0.01% 2451
2024
Q3 		$1.8M Sell
20,082
-586
-3% -$51.2K ﹤0.01% 2733
2024
Q2 		$1.66M Buy
20,668
+813
+4% +$60.2K ﹤0.01% 2702
2024
Q1 		$1.58M Buy
19,855
+4,263
+27% +$358K ﹤0.01% 2721
2023
Q4 		$1.24M Sell
15,592
-346
-2% -$23.1K ﹤0.01% 2776
2023
Q3 		$1.11M Buy
15,938
+3,008
+23% +$225K ﹤0.01% 2738
2023
Q2 		$929K Buy
12,930
+2,457
+23% +$181K ﹤0.01% 2810
2023
Q1 		$646K Sell
10,473
-1,548
-13% -$102K ﹤0.01% 2978
2022
Q4 		$927K Sell
12,021
-2,760
-19% -$165K ﹤0.01% 2698
2022
Q3 		$660K Buy
14,781
+3,949
+36% +$197K ﹤0.01% 2851
2022
Q2 		$415K Buy
10,832
+3,104
+40% +$98.2K ﹤0.01% 3162
2022
Q1 		$320K Sell
7,728
-1,130
-13% -$35K ﹤0.01% 3413
2021
Q4 		$335K Sell
8,858
-3,308
-27% -$122K ﹤0.01% 3343
2021
Q3 		$401K Buy
12,166
+531
+5% +$20.7K ﹤0.01% 3112
2021
Q2 		$785K Buy
11,635
+2,336
+25% +$140K ﹤0.01% 2688
2021
Q1 		$527K Buy
+9,299
New +$654K ﹤0.01% 2812

Other funds holding AXSM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Envestnet Asset Management's AXSM Position: Q1 2026 in Review

Envestnet Asset Management increased its Axsome Therapeutics (AXSM) stake by 0.21% in Q1 2026, buying an estimated $11.1K and bringing the position to 30,555 shares worth $5.16M. The position accounts for ﹤0.01% of the portfolio, ranked #2292.

Envestnet Asset Management first reported a position in AXSM in Q1 2021 and has held it in 21 quarters since. The position peaked at $5.57M in Q4 2025. 409 funds tracked by Wall St. Rank hold AXSM as of Q1 2026.

  • Envestnet Asset Management held 30,555 shares of Axsome Therapeutics worth $5.16M as of Q1 2026.
  • Envestnet Asset Management bought 64 Axsome Therapeutics shares in Q1 2026, an estimated $11.1K.
  • Axsome Therapeutics made up ﹤0.01% of Envestnet Asset Management's portfolio in Q1 2026, its #2292 holding.
  • Envestnet Asset Management first reported a position in Axsome Therapeutics in Q1 2021 and has held it in 21 quarters since.
  • Envestnet Asset Management's Axsome Therapeutics position peaked at $5.57M in Q4 2025.
  • 409 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q1 2026.

Based on Envestnet Asset Management's 13F filing for Q1 2026, filed 4 May 2026.